Featured Topics
Calendar

August 06, 2025

Q2 2025 Results / Quarterly Statement
Bayer Q2 Media Update

November 12, 2025

Q3 2025 Results / Quarterly Statement
Press Releases
Share Price / Index
May 23, 2025
Not intended for U.S. and UK Media
Eylea™ 8 mg with extended 6-month treatment interval recommended for approval in EU
May 22, 2025
Not intended for U.S. and UK Media
Eylea™ 8 mg approved in China for wet age-related macular degeneration
May 13, 2025
First-quarter performance:
Bayer confirms 2025 targets after solid start to the year

Our Products

Our broad product portfolio includes many world-famous brands that have shaped our Bayer brand. With our products, we are helping to find solutions to some of the greatest challenges of our time. So that health and nutrition can be made available to everyone.